UNIVERSAL HEALTH SERVICES INC

Listed Company

UHSCIK 0000352915NYSELarge AcceleratedServices-General Medical & Surgical Hospitals, NecDelawareFY ends Dec 31

Period

FY 2025

Revenue

$17.36B

Net Income

$1.49B

Total Assets

$15.53B

Equity

$7.28B

Shares Out

—

Op. Cash Flow

$1.86B

Business

UNIVERSAL HEALTH SERVICES INC owns and operates acute care hospitals, outpatient centers and behavioral health facilities through its subsidiaries. It provides services including general and specialty surgery, emergency care, internal medicine, obstetrics, radiology, oncology, diagnostic services, pharmacy services and behavioral health treatment, and also offers capital, purchasing, information, finance and management services to facilities. The company’s key business segments are Acute Care Hospitals and Behavioral Health Services, plus advisory and joint-venture arrangements. Its operations and distribution channels span owned and leased inpatient and outpatient facilities, free-standing emergency departments, joint ventures and leased properties in the U.S., the U.K. and Puerto Rico.

Summary from filing dated 2025-02-26

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Net revenues	17,365	15,828	14,282	13,399	12,642
Salaries, wages and benefits	8,085	7,519	7,107	6,762	6,164
Other operating expenses	4,860	4,308	3,757	3,446	3,036
Supplies expense	1,659	1,588	1,533	1,474	1,427
Depreciation and amortization	619	585	568	582	533
Lease and rental expense	148	146	141	132	119
Operating Expenses, Total	15,371	14,146	13,107	12,396	11,279
Income from operations	1,994	1,682	1,175	1,004	1,363
Interest expense, net	156	186	207	127	84
Other (income) expense, net	−134	−2	28	10	−14
Income before income taxes	1,972	1,498	940	866	1,293
Provision for income taxes	461	335	221	209	306
Net income	1,511	1,163	719	657	988
Less: Net income (loss) attributable to noncontrolling interests	22	21	2	−19	−4
Net income attributable to UHS	1,489	1,142	718	676	992
Basic earnings per share attributable to UHS	23.42	17.16	10.35	9.23	11.99
Diluted earnings per share attributable to UHS	23.1	16.82	10.23	9.14	11.82
Weighted average number of common sharesbasic	64	67	69	73	83
Add: Other share equivalents	881,000	1	804,000	714,000	1
Weighted average number of common shares and equivalentsdiluted	64	68	70	74	84

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Cash and cash equivalents	138	126	119	103	115
Accounts receivable, net	2,602	2,178	2,238	2,018	1,747
Supplies	232	221	217	219	207
Other current assets	436	292	237	198	195
Total current assets	3,408	2,816	2,811	2,537	2,264
Land	759	746	737	727	733
Buildings and improvements	8,076	7,671	7,140	6,756	6,510
Equipment	3,394	3,260	3,066	2,937	2,760
Property under finance lease	129	125	101	102	103
Property Equipment Gross	12,358	11,802	11,045	10,523	10,105
Accumulated depreciation	−6,482	−6,071	−5,653	−5,167	−4,896
Property and equipment excluding construction in progress net	5,877	5,731	5,392	5,356	5,209
Construction-in-progress	1,131	841	732	563	665
Property, plant and equipment, net, Total	7,008	6,572	6,125	5,918	5,874
Goodwill	3,990	3,933	3,932	3,909	3,963
Deferred income taxes	71	118	86	68	46
Right of use assets-operating leases	374	419	434	455	367
Deferred charges	9	9	7	6	7
Other	667	602	573	600	573
Other assets	5,112	5,081	5,032	5,038	4,956
Total Assets	15,528	14,470	13,968	13,494	13,094
Current maturities of long-term debt	748	40	127	81	48
Accounts payable	750	632	614	637	659
Compensation and related benefits	682	623	549	471	466
Interest	26	30	17	16	14
Taxes other than income	268	162	154	111	161
Operating lease liabilities	73	75	72	68	64
Other	690	635	473	524	560
Current federal and state income taxes	2	14	2	5	11
Total current liabilities	3,240	2,210	2,013	1,914	1,984
Other noncurrent liabilities	528	656	584	488	465
Operating lease liabilities noncurrent	341	376	383	396	305
Deferred income taxes	6	0	—	—	0
Long-term debt	4,004	4,464	4,786	4,727	4,142
Commitments and contingencies (Note 8)	—	—	—	—	—
Redeemable noncontrolling interest	71	13	5	5	5
Cumulative dividends	−765	−714	−660	−604	−545
Retained earnings	7,993	7,372	6,799	6,534	6,604
Accumulated other comprehensive income	48	7	9	−10	30
Universal Health Services, Inc. common stockholders equity	7,276	6,666	6,149	5,921	6,090
Noncontrolling interest	63	83	48	45	103
Total Equity	7,339	6,750	6,197	5,965	6,193
Total Liabilities and Stockholders Equity	15,528	14,470	13,968	13,494	13,094

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Depreciation & amortization	619	585	568	582	533
Stock-based compensation expense	96	99	88	85	74
Unrealized gain on non-marketable securities	−93	0	0	—	—
Loss (gain) on sales of assets and businesses	8	−10	−6	584,000	−5
Costs related to extinguishment of debt	0	3	0	0	17
Accounts receivable	−318	67	−182	−258	−9
Accrued interest	−4	13	1	2	5
Accrued and deferred income taxes	−21	13	−43	−30	−54
Other working capital accounts	99	62	−32	−147	47
Other assets and deferred charges	−29	−12	49	20	−39
Other, net	20	22	39	−9	−82
Accrued insurance expense, net of commercial premiums paid	237	254	183	175	186
Payments made in settlement of self-insurance claims, net of commercial insurance reimbursements	−259	−192	−118	—	—
Deferred grant revenue	0	0	3	2	—
Net cash provided by operating activities	1,864	2,067	1,268	996	884
Property and equipment additions	−1,015	−944	−743	−734	−856
Proceeds received from sales of assets and businesses	16	39	24	12	25
Acquisition of businesses and property	−48	−19	−4	−20	−105
(Outflows) inflows from foreign exchange contracts that hedge our net U.K. investment.	−52	13	−41	95	1
Costs incurred for purchase and development of enterprise resource planning application	−25	0	0	—	—
Proceeds received from sale of marketable equity securities	63	0	0	—	—
Investments in non-marketable securities	−10	0	0	—	—
Decrease in capital reserves of commercial insurance subsidiary	142,000	276,000	16,000	100,000	100,000
Net cash used in investing activities	−1,071	−911	−763	−647	−914
Repayments of long-term debt	−44	−2,640	−85	−89	−3,038
Additional borrowings	286	2,210	185	705	3,255
Financing costs	−382,000	−13	−308,000	−3	−19
Repurchase of common shares	−968	−671	−547	−833	−1,221
Dividends paid	−51	−53	−55	−58	−66
Issuance of common stock	17	15	14	14	13
Profit distributions to noncontrolling interests	−12	−7	−7	−5	−7
Purchase of ownership interests by minority members	23	13	3	−49	13
Net cash used in financing activities	−750	−1,145	−494	−318	−1,069
Effect of exchange rate changes on cash and cash equivalents	3	−833,000	3	−8	−499,000
Increase in cash, cash equivalents and restricted cash	47	10	14	22	−1,100
Interest paid	156	168	200	120	76
Income taxes paid, net of refunds	471	325	258	251	363
Noncash purchases of property and equipment	74	118	67	72	167

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro